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Background: Plaque rupture is mainly implicated in the pathogenesis of acute coronary syndrome (ACS). There are no in vivo studies regarding 
the relationship between the clinical type of ACS and morphology of plaque. Optical coherence tomography has enabled the discrimination between 
microstructures of vulnerable plaque in vivo. We hypothesized that there are distinct differences in the morphology of ruptured plaques between 
patients with non-ST elevation ACS (NSTACS) and patients with ST elevation myocardial infarction (STEMI).
Methods: We studied 33 patients with ACS with ruptured culprit lesion (CL). Patients were divided in 2 groups according to the clinical 
presentation of ACS; patients with NSTACS and STEMI. Plaque rupture was defined as presence of fibrous cap discontinuity. CL was identified by 
a combination of ECG, transthoracic echocardiogram and coronary angiography. Thereafter, optical coherence tomography image acquisition was 
performed in CL, before any balloon dilatation or stent deployment.
Results: Thirteen patients with NSTACS and 20 patients with STEMI were studied. In patients with NSTACS, mean length of plaque disruption 
was 1.31±0.48mm, while in patients with STEMI mean length was 2.47±2.32mm (p<0.05). Mean fibrous cap thickness was similar between the 
two groups (47±27 vs. 47±16μm, p=0.99). Although cross-sectional area (CSA) of minimal lumen site was greater in patients with NSTACS vs 
STEMI (2.57±2.27mm2 vs. 1.27±0.76 mm2, p=0.03), no significant differences were found regarding CSA of the rupture site (4.15±3mm2 vs. 
3.9±2.59mm2, p=0.83). No significant differences were found regarding the distance of rupture from the site of minimal lumen area (2.17±3.94 
mm vs. 0.78±3.00 mm, p=0.37), the length of missing fibrous cap (0.5±0.3mm vs. 0.62±0.48, p=0.58) and the incidence of plaques broken at cap 
shoulder (61.53% vs. 68.42%, p=0.72).
Conclusions: Patients with STEMI have CLs with greater length of rupture compared to patients with NSTACS. The identification of the 
morphological differences in vivo between clinical types of ACS could give investigators a key for better understanding of the pathophysiological 
mechanisms responsible for the clinical onset of ACS.
